Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1989 Nov;210(5):653–657. doi: 10.1097/00000658-198911000-00014

Natural history of in situ breast cancer in a defined population.

W J Temple 1, M Jenkins 1, F Alexander 1, W S Hwang 1, L H Marx 1, A W Lees 1, H T Williams 1, M G Pambrun 1
PMCID: PMC1357803  PMID: 2554827

Abstract

The entire experience of in situ breast cancer in Alberta from 1953 to 1984 was examined. Of 243 patients coded, 226 were available for review by a panel of three pathologists. In 149 cases the diagnosis of in situ disease was confirmed. One hundred and eight patients had 109 ductal carcinomas in situ, 38 patients had lobular carcinomas in situ, with 3 patients having both. A multitude of treatments was used, ranging from local excision to radical mastectomy. Survival at a mean of 6 years follow-up was equal in all groups, with only two patients with a confirmed diagnosis of ductal carcinoma in situ dying from clinically suspected systemic disease. In patients treated by local excision, ipsilateral cancers were seen in 12% of ductal carcinoma in situ patients who had local excision and 13% of patients with lobular carcinoma in situ. Contralateral metachronous invasive cancers were seen in 6% of ductal carcinoma in situ patients and 3% of lobular carcinoma in situ patients. No lymph node involvement was seen in any of these patients, either with prophylactic dissection or in follow-up. The conclusion reached was that both in situ lesions are similar in their clinical course. Lymph node dissection is not necessary. Pathologic review is critical for accurate studies, with a change in diagnosis of 36% of diagnoses. Treatment does not appear to affect prognosis. The most appropriate treatment needs to be determined in prospective randomized trials.

Full text

PDF
653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen J. A. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer. 1977 Jun;39(6):2597–2602. doi: 10.1002/1097-0142(197706)39:6<2597::aid-cncr2820390644>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  2. Betsill W. L., Jr, Rosen P. P., Lieberman P. H., Robbins G. F. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA. 1978 May 5;239(18):1863–1867. doi: 10.1001/jama.239.18.1863. [DOI] [PubMed] [Google Scholar]
  3. Brown P. W., Silverman J., Owens E., Tabor D. C., Terz J. J., Lawrence W., Jr Intraductal "noninfiltrating" carcinoma of the breast. Arch Surg. 1976 Oct;111(10):1063–1067. doi: 10.1001/archsurg.1976.01360280021003. [DOI] [PubMed] [Google Scholar]
  4. Carter D., Smith R. R. Carcinoma in situ of the breast. Cancer. 1977 Sep;40(3):1189–1193. doi: 10.1002/1097-0142(197709)40:3<1189::aid-cncr2820400330>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  5. Fisher E. R., Sass R., Fisher B., Wickerham L., Paik S. M. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer. 1986 Jan 15;57(2):197–208. doi: 10.1002/1097-0142(19860115)57:2<197::aid-cncr2820570203>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  6. Haagensen C. D., Lane N., Lattes R., Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978 Aug;42(2):737–769. doi: 10.1002/1097-0142(197808)42:2<737::aid-cncr2820420247>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  7. Holland R., Veling S. H., Mravunac M., Hendriks J. H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985 Sep 1;56(5):979–990. doi: 10.1002/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  8. Lagios M. D., Westdahl P. R., Margolin F. R., Rose M. R. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982 Oct 1;50(7):1309–1314. doi: 10.1002/1097-0142(19821001)50:7<1309::aid-cncr2820500716>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  9. Nielsen M., Christensen L., Andersen J. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer. 1986 Mar 1;57(5):897–903. doi: 10.1002/1097-0142(19860301)57:5<897::aid-cncr2820570502>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Page D. L., Dupont W. D., Rogers L. W., Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982 Feb 15;49(4):751–758. doi: 10.1002/1097-0142(19820215)49:4<751::aid-cncr2820490426>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  11. Page D. L., Dupont W. D., Rogers L. W., Rados M. S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985 Jun 1;55(11):2698–2708. doi: 10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  12. Recht A., Danoff B. S., Solin L. J., Schnitt S., Connolly J., Botnick L., Goldberg I., Goodman R. L., Harris J. R. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol. 1985 Oct;3(10):1339–1343. doi: 10.1200/JCO.1985.3.10.1339. [DOI] [PubMed] [Google Scholar]
  13. Rosen P. P., Braun D. W., Jr, Lyngholm B., Urban J. A., Kinne D. W. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer. 1981 Feb 15;47(4):813–819. doi: 10.1002/1097-0142(19810215)47:4<813::aid-cncr2820470431>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  14. Rosen P. P., Senie R., Schottenfeld D., Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979 Mar;189(3):377–382. doi: 10.1097/00000658-197903000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosner D., Bedwani R. N., Vana J., Baker H. W., Murphy G. P. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg. 1980 Aug;192(2):139–147. doi: 10.1097/00000658-198008000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schnitt S. J., Silen W., Sadowsky N. L., Connolly J. L., Harris J. R. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med. 1988 Apr 7;318(14):898–903. doi: 10.1056/NEJM198804073181406. [DOI] [PubMed] [Google Scholar]
  17. Silverstein M. J., Rosser R. J., Gierson E. D., Waisman J. R., Gamagami P., Hoffman R. S., Fingerhut A. G., Lewinsky B. S., Colburn W., Handel N. Axillary lymph node dissection for intraductal breast carcinoma--is it indicated? Cancer. 1987 May 15;59(10):1819–1824. doi: 10.1002/1097-0142(19870515)59:10<1819::aid-cncr2820591023>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Sunshine J. A., Moseley H. S., Fletcher W. S., Krippaehne W. W. Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up. Am J Surg. 1985 Jul;150(1):44–51. doi: 10.1016/0002-9610(85)90008-x. [DOI] [PubMed] [Google Scholar]
  19. Zafrani B., Fourquet A., Vilcoq J. R., Legal M., Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer. 1986 Apr 1;57(7):1299–1301. doi: 10.1002/1097-0142(19860401)57:7<1299::aid-cncr2820570708>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES